speb/financial-data huggingface dataset:
CBT cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -3000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Payable: -26000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -26000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -11000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Receivables: -48000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 2000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -88000000.00
CBT cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Common Stock: 54000000.00
CBT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -23000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1427000000.00
CBT cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CBT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -47000000.00
CBT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 695000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Current Assets: 1603000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Current Debt: 199000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 199000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 818000000.00
CBT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 8000000.00
CBT cash_flow (quarterly, 2025-03-31) — Deferred Tax: 8000000.00
CBT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 38000000.00
CBT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 38000000.00
CBT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 54400000.00
CBT income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.69
CBT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 92000000.00
CBT cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 0.00
CBT income_statement (quarterly, 2025-03-31) — EBIT: 170000000.00
CBT income_statement (quarterly, 2025-03-31) — EBITDA: 208000000.00
CBT income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: 3000000.00
CBT cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -3000000.00
CBT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 10000000.00
CBT cash_flow (quarterly, 2025-03-31) — End Cash Position: 213000000.00
CBT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 17000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Finished Goods: 333000000.00
CBT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -26000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -427000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Goodwill: 128000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 183000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 744000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4155000000.00
CBT income_statement (quarterly, 2025-03-31) — Gross Profit: 241000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 42000000.00
CBT income_statement (quarterly, 2025-03-31) — Interest Expense: 19000000.00
CBT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 19000000.00
CBT income_statement (quarterly, 2025-03-31) — Interest Income: 7000000.00
CBT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 7000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Inventory: 541000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2716000000.00
CBT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -70000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 14000000.00
CBT cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CBT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 90000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1090000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1090000000.00
CBT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CBT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 14000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Minority Interest: 163000000.00
CBT income_statement (quarterly, 2025-03-31) — Minority Interests: -11000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 27000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -47000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Net Debt: 1076000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income: 94000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 92000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 105000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 94000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 94000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 105000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 105000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Interest Income: -12000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 87000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -3000000.00
CBT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -12000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
CBT balance_sheet (quarterly, 2025-03-31) — Net PPE: 1603000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -72000000.00
CBT cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 90000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1244000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 204000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 39000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 204000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 39000000.00
CBT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 208000000.00
CBT income_statement (quarterly, 2025-03-31) — Normalized Income: 94000000.00
CBT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 73000000.00
CBT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -3000000.00
CBT income_statement (quarterly, 2025-03-31) — Operating Income: 162000000.00
CBT income_statement (quarterly, 2025-03-31) — Operating Revenue: 936000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 53700563.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 110000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -427000000.00
CBT income_statement (quarterly, 2025-03-31) — Other Income Expense: 1000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 55000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Inventories: 61000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 177000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 247000000.00
CBT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1000000.00
CBT income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 2000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Payables: 619000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 619000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CBT income_statement (quarterly, 2025-03-31) — Pretax Income: 151000000.00
CBT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 27000000.00
CBT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -72000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Raw Materials: 147000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Receivables: 739000000.00
CBT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 695000000.00
CBT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 38000000.00
CBT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3000000.00
CBT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -47000000.00
CBT income_statement (quarterly, 2025-03-31) — Research And Development: 15000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1803000000.00
CBT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 64000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Share Issued: 53832031.00
CBT cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 90000000.00
CBT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1427000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1244000000.00
CBT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (quarterly, 2025-03-31) — Tax Provision: 49000000.00
CBT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
CBT balance_sheet (quarterly, 2025-03-31) — Total Assets: 3784000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2517000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Debt: 1289000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1590000000.00
CBT income_statement (quarterly, 2025-03-31) — Total Expenses: 774000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2194000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2181000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1376000000.00
CBT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 162000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 42000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 131468.00
CBT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 3000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Working Capital: 785000000.00
CBT income_statement (quarterly, 2025-06-30) — +Operating Expense: 77000000.00
CBT income_statement (quarterly, 2025-06-30) — +Total Revenue: 923000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 596000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 689000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2658000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 0.00
CBT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 0.00
CBT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 53500000.00
CBT income_statement (quarterly, 2025-06-30) — Basic EPS: 1.87
CBT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 213000000.00
CBT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -34000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 53000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 239000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 239000000.00
CBT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -24000000.00
CBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -183000000.00
CBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -65000000.00
CBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 249000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -10000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Inventory: 27000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Payable: -13000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -13000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -8000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Receivables: 77000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -10000000.00
CBT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 83000000.00
CBT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Common Stock: 53000000.00
CBT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -24000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1541000000.00
CBT cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CBT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -40000000.00
CBT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 679000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Current Assets: 1573000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Current Debt: 110000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 110000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 740000000.00
CBT cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 1000000.00
CBT cash_flow (quarterly, 2025-06-30) — Deferred Tax: 1000000.00
CBT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 39000000.00
CBT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 39000000.00
CBT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 53800000.00
CBT income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.86
CBT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 100000000.00
CBT cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 1000000.00
CBT income_statement (quarterly, 2025-06-30) — EBIT: 174000000.00
CBT income_statement (quarterly, 2025-06-30) — EBITDA: 213000000.00
CBT income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 1000000.00
CBT cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -1000000.00
CBT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 25000000.00
CBT cash_flow (quarterly, 2025-06-30) — End Cash Position: 239000000.00
CBT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -183000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 322000000.00
CBT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 215000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -355000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Goodwill: 133000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 189000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 694000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4330000000.00
CBT income_statement (quarterly, 2025-06-30) — Gross Profit: 244000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 34000000.00
CBT income_statement (quarterly, 2025-06-30) — Interest Expense: 19000000.00
CBT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 19000000.00
CBT income_statement (quarterly, 2025-06-30) — Interest Income: 7000000.00
CBT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 7000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Inventory: 531000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2756000000.00
CBT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -65000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 15000000.00
CBT cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CBT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -70000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1105000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1105000000.00
CBT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 9000000.00
CBT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 15000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Minority Interest: 142000000.00
CBT income_statement (quarterly, 2025-06-30) — Minority Interests: -12000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -40000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Net Debt: 976000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income: 101000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 100000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 113000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 101000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 101000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 113000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 113000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Interest Income: -12000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -82000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 8000000.00
CBT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -12000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -37000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -31000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Net PPE: 1672000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -61000000.00
CBT cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -90000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1352000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 207000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 40000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 207000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 40000000.00
CBT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 213000000.00
CBT income_statement (quarterly, 2025-06-30) — Normalized Income: 101000000.00
CBT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 249000000.00
CBT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1000000.00
CBT income_statement (quarterly, 2025-06-30) — Operating Income: 167000000.00
CBT income_statement (quarterly, 2025-06-30) — Operating Revenue: 923000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 53203216.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 114000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -355000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 56000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Inventories: 64000000.00
CBT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 8000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 181000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 269000000.00
CBT income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 1000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Payables: 630000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 630000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CBT income_statement (quarterly, 2025-06-30) — Pretax Income: 155000000.00
CBT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -61000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 145000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Receivables: 689000000.00
CBT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 679000000.00
CBT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 39000000.00
CBT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -12000000.00
CBT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -40000000.00
CBT income_statement (quarterly, 2025-06-30) — Research And Development: 15000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1846000000.00
CBT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 62000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Share Issued: 53334316.00
CBT cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: -79000000.00
CBT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1541000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1352000000.00
CBT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (quarterly, 2025-06-30) — Tax Provision: 43000000.00
CBT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
CBT balance_sheet (quarterly, 2025-06-30) — Total Assets: 3837000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2646000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Debt: 1215000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1683000000.00
CBT income_statement (quarterly, 2025-06-30) — Total Expenses: 756000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2154000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2264000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1414000000.00
CBT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 167000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 34000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 131100.00
CBT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 3000000.00
CBT balance_sheet (quarterly, 2025-06-30) — Working Capital: 833000000.00
CBT income_statement (annual, 2025-09-30) — +Operating Expense: 319000000.00
CBT income_statement (quarterly, 2025-09-30) — +Operating Expense: 83000000.00
CBT income_statement (annual, 2025-09-30) — +Total Revenue: 3713000000.00
CBT income_statement (quarterly, 2025-09-30) — +Total Revenue: 899000000.00
CBT balance_sheet (annual, 2025-09-30) — Accounts Payable: 459000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 459000000.00
CBT balance_sheet (annual, 2025-09-30) — Accounts Receivable: 671000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 671000000.00
CBT balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -2694000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2694000000.00
CBT balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 0.00
CBT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
CBT balance_sheet (annual, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (annual, 2025-09-30) — Average Dilution Earnings: 0.00
CBT income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
CBT income_statement (annual, 2025-09-30) — Basic Average Shares: 53700000.00
CBT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 53100000.00
CBT income_statement (annual, 2025-09-30) — Basic EPS: 6.07
CBT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.79
CBT cash_flow (annual, 2025-09-30) — Beginning Cash Position: 223000000.00
CBT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 239000000.00
CBT balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 672000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 672000000.00
CBT cash_flow (annual, 2025-09-30) — Capital Expenditure: -274000000.00
CBT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -64000000.00
CBT balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 85000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 85000000.00
CBT balance_sheet (annual, 2025-09-30) — Capital Stock: 53000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 53000000.00
CBT balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 258000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 258000000.00
CBT balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 258000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 258000000.00
CBT cash_flow (annual, 2025-09-30) — Cash Dividends Paid: -96000000.00
CBT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -25000000.00
CBT cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: -336000000.00
CBT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -146000000.00
CBT cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -298000000.00
CBT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -59000000.00
CBT cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 665000000.00
CBT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 219000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Account Payable: -67000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 12000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Income Tax Payable: -8000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 2000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Inventory: 47000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Inventory: 28000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Other Current Liabilities: 2000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -5000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Payable: -75000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Payable: 14000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: -75000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 14000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -1000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 24000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Receivables: 76000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 29000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Tax Payable: -8000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 2000000.00
CBT cash_flow (annual, 2025-09-30) — Change In Working Capital: 49000000.00
CBT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 90000000.00
CBT cash_flow (annual, 2025-09-30) — Changes In Cash: 31000000.00
CBT cash_flow (quarterly, 2025-09-30) — Changes In Cash: 14000000.00
CBT balance_sheet (annual, 2025-09-30) — Commercial Paper: 6000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 6000000.00
CBT balance_sheet (annual, 2025-09-30) — Common Stock: 53000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Common Stock: 53000000.00
CBT cash_flow (annual, 2025-09-30) — Common Stock Dividend Paid: -96000000.00
CBT cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -25000000.00
CBT balance_sheet (annual, 2025-09-30) — Common Stock Equity: 1550000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1550000000.00
CBT cash_flow (annual, 2025-09-30) — Common Stock Issuance: 8000000.00
CBT cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 6000000.00
CBT cash_flow (annual, 2025-09-30) — Common Stock Payments: -168000000.00
CBT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -39000000.00
CBT balance_sheet (annual, 2025-09-30) — Construction In Progress: 457000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 457000000.00
CBT income_statement (annual, 2025-09-30) — Cost Of Revenue: 2773000000.00
CBT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 679000000.00
CBT balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 112000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 112000000.00
CBT balance_sheet (annual, 2025-09-30) — Current Assets: 1539000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Current Assets: 1539000000.00
CBT balance_sheet (annual, 2025-09-30) — Current Debt: 274000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Current Debt: 274000000.00
CBT balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 274000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 274000000.00
CBT balance_sheet (annual, 2025-09-30) — Current Liabilities: 957000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 957000000.00
CBT cash_flow (annual, 2025-09-30) — Deferred Income Tax: 32000000.00
CBT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 23000000.00
CBT cash_flow (annual, 2025-09-30) — Deferred Tax: 32000000.00
CBT cash_flow (quarterly, 2025-09-30) — Deferred Tax: 23000000.00
CBT cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 154000000.00
CBT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 40000000.00
CBT cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 154000000.00
CBT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 40000000.00
CBT income_statement (annual, 2025-09-30) — Diluted Average Shares: 54200000.00
CBT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 53400000.00
CBT income_statement (annual, 2025-09-30) — Diluted EPS: 6.02
CBT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.79
CBT income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: 326000000.00
CBT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 42000000.00
CBT cash_flow (annual, 2025-09-30) — Dividend Received Cfo: 13000000.00
CBT cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 0.00
CBT income_statement (annual, 2025-09-30) — EBIT: 641000000.00
CBT income_statement (quarterly, 2025-09-30) — EBIT: 135000000.00
CBT income_statement (annual, 2025-09-30) — EBITDA: 795000000.00
CBT income_statement (quarterly, 2025-09-30) — EBITDA: 175000000.00
CBT income_statement (annual, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 7000000.00
CBT income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 2000000.00
CBT cash_flow (annual, 2025-09-30) — Earnings Losses From Equity Investments: -7000000.00
CBT cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -2000000.00
CBT cash_flow (annual, 2025-09-30) — Effect Of Exchange Rate Changes: 4000000.00
CBT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 5000000.00
CBT balance_sheet (annual, 2025-09-30) — Employee Benefits: 49000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 49000000.00
CBT cash_flow (annual, 2025-09-30) — End Cash Position: 258000000.00
CBT cash_flow (quarterly, 2025-09-30) — End Cash Position: 258000000.00
CBT cash_flow (annual, 2025-09-30) — Financing Cash Flow: -336000000.00
CBT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -146000000.00
CBT balance_sheet (annual, 2025-09-30) — Finished Goods: 303000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Finished Goods: 303000000.00
CBT cash_flow (annual, 2025-09-30) — Free Cash Flow: 391000000.00
CBT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 155000000.00
CBT cash_flow (annual, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
CBT cash_flow (annual, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CBT income_statement (annual, 2025-09-30) — Gain On Sale Of Business: 0.00
CBT balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -335000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -335000000.00
CBT balance_sheet (annual, 2025-09-30) — Goodwill: 134000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Goodwill: 134000000.00
CBT balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 189000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 189000000.00
CBT balance_sheet (annual, 2025-09-30) — Gross Accounts Receivable: 676000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 676000000.00
CBT balance_sheet (annual, 2025-09-30) — Gross PPE: 4405000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4405000000.00
CBT income_statement (annual, 2025-09-30) — Gross Profit: 940000000.00
CBT income_statement (quarterly, 2025-09-30) — Gross Profit: 220000000.00
CBT cash_flow (annual, 2025-09-30) — Income Tax Paid Supplemental Data: 165000000.00
CBT balance_sheet (annual, 2025-09-30) — Income Tax Payable: 35000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 35000000.00
CBT income_statement (annual, 2025-09-30) — Interest Expense: 76000000.00
CBT income_statement (quarterly, 2025-09-30) — Interest Expense: 20000000.00
CBT income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 76000000.00
CBT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 20000000.00
CBT income_statement (annual, 2025-09-30) — Interest Income: 27000000.00
CBT income_statement (quarterly, 2025-09-30) — Interest Income: 7000000.00
CBT income_statement (annual, 2025-09-30) — Interest Income Non Operating: 27000000.00
CBT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 7000000.00
CBT cash_flow (annual, 2025-09-30) — Interest Paid Supplemental Data: 79000000.00
CBT balance_sheet (annual, 2025-09-30) — Inventory: 504000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Inventory: 504000000.00
CBT balance_sheet (annual, 2025-09-30) — Invested Capital: 2680000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2680000000.00
CBT cash_flow (annual, 2025-09-30) — Investing Cash Flow: -298000000.00
CBT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -59000000.00
CBT balance_sheet (annual, 2025-09-30) — Investments And Advances: 16000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 16000000.00
CBT cash_flow (annual, 2025-09-30) — Issuance Of Capital Stock: 8000000.00
CBT cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 6000000.00
CBT cash_flow (annual, 2025-09-30) — Issuance Of Debt: 34000000.00
CBT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -47000000.00
CBT balance_sheet (annual, 2025-09-30) — Land And Improvements: 74000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 74000000.00
CBT balance_sheet (annual, 2025-09-30) — Line Of Credit: 8000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 8000000.00
CBT balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 85000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 85000000.00
CBT balance_sheet (annual, 2025-09-30) — Long Term Debt: 856000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 856000000.00
CBT balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 941000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 941000000.00
CBT cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 15000000.00
CBT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CBT cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -7000000.00
CBT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2000000.00
CBT balance_sheet (annual, 2025-09-30) — Long Term Equity Investment: 16000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 16000000.00
CBT balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 2957000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2957000000.00
CBT balance_sheet (annual, 2025-09-30) — Minority Interest: 155000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Minority Interest: 155000000.00
CBT income_statement (annual, 2025-09-30) — Minority Interests: -45000000.00
CBT income_statement (quarterly, 2025-09-30) — Minority Interests: -11000000.00
CBT cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: 0.00
CBT cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: -160000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -33000000.00
CBT balance_sheet (annual, 2025-09-30) — Net Debt: 872000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Net Debt: 872000000.00
CBT income_statement (annual, 2025-09-30) — Net Income: 331000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income: 43000000.00
CBT income_statement (annual, 2025-09-30) — Net Income Common Stockholders: 326000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 42000000.00
CBT income_statement (annual, 2025-09-30) — Net Income Continuous Operations: 376000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 54000000.00
CBT income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 331000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 43000000.00
CBT income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 331000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 43000000.00
CBT cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: 376000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 54000000.00
CBT income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: 376000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 54000000.00
CBT income_statement (annual, 2025-09-30) — Net Interest Income: -49000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Interest Income: -13000000.00
CBT cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: -23000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -88000000.00
CBT cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: 8000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -2000000.00
CBT income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: -49000000.00
CBT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -13000000.00
CBT cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -57000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CBT cash_flow (annual, 2025-09-30) — Net Other Investing Changes: -24000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 5000000.00
CBT balance_sheet (annual, 2025-09-30) — Net PPE: 1711000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Net PPE: 1711000000.00
CBT cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -274000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -64000000.00
CBT cash_flow (annual, 2025-09-30) — Net Short Term Debt Issuance: -31000000.00
CBT cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -86000000.00
CBT balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 1361000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1361000000.00
CBT balance_sheet (annual, 2025-09-30) — Non Current Accrued Expenses: 124000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 124000000.00
CBT balance_sheet (annual, 2025-09-30) — Non Current Deferred Assets: 180000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 180000000.00
CBT balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 39000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 39000000.00
CBT balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Assets: 180000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 180000000.00
CBT balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Liabilities: 39000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 39000000.00
CBT income_statement (annual, 2025-09-30) — Normalized EBITDA: 795000000.00
CBT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 175000000.00
CBT income_statement (annual, 2025-09-30) — Normalized Income: 331000000.00
CBT income_statement (quarterly, 2025-09-30) — Normalized Income: 43000000.00
CBT cash_flow (annual, 2025-09-30) — Operating Cash Flow: 665000000.00
CBT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 219000000.00
CBT cash_flow (annual, 2025-09-30) — Operating Gains Losses: -7000000.00
CBT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2000000.00
CBT income_statement (annual, 2025-09-30) — Operating Income: 621000000.00
CBT income_statement (quarterly, 2025-09-30) — Operating Income: 137000000.00
CBT income_statement (annual, 2025-09-30) — Operating Revenue: 3713000000.00
CBT income_statement (quarterly, 2025-09-30) — Operating Revenue: 899000000.00
CBT balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 52842481.00
CBT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 52842481.00
CBT balance_sheet (annual, 2025-09-30) — Other Current Assets: 106000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 106000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Current Borrowings: 260000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 260000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Equity Adjustments: -335000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -335000000.00
CBT income_statement (annual, 2025-09-30) — Other Income Expense: -7000000.00
CBT income_statement (quarterly, 2025-09-30) — Other Income Expense: -9000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 55000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 55000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Inventories: 67000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Inventories: 67000000.00
CBT cash_flow (annual, 2025-09-30) — Other Non Cash Items: 24000000.00
CBT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 9000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Non Current Assets: 180000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 180000000.00
CBT income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: -7000000.00
CBT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -9000000.00
CBT balance_sheet (annual, 2025-09-30) — Other Properties: 245000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Other Properties: 245000000.00
CBT income_statement (annual, 2025-09-30) — Otherunder Preferred Stock Dividend: 5000000.00
CBT income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 1000000.00
CBT balance_sheet (annual, 2025-09-30) — Payables: 494000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Payables: 494000000.00
CBT balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 606000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 606000000.00
CBT balance_sheet (annual, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 77000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 77000000.00
CBT balance_sheet (annual, 2025-09-30) — Preferred Stock: 0.00
CBT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CBT income_statement (annual, 2025-09-30) — Pretax Income: 565000000.00
CBT income_statement (quarterly, 2025-09-30) — Pretax Income: 115000000.00
CBT balance_sheet (annual, 2025-09-30) — Properties: 0.00
CBT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CBT cash_flow (annual, 2025-09-30) — Purchase Of PPE: -274000000.00
CBT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -64000000.00
CBT balance_sheet (annual, 2025-09-30) — Raw Materials: 134000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Raw Materials: 134000000.00
CBT balance_sheet (annual, 2025-09-30) — Receivables: 671000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Receivables: 671000000.00
CBT income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 2773000000.00
CBT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 679000000.00
CBT income_statement (annual, 2025-09-30) — Reconciled Depreciation: 154000000.00
CBT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 40000000.00
CBT cash_flow (annual, 2025-09-30) — Repayment Of Debt: -57000000.00
CBT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -41000000.00
CBT cash_flow (annual, 2025-09-30) — Repurchase Of Capital Stock: -168000000.00
CBT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -39000000.00
CBT income_statement (annual, 2025-09-30) — Research And Development: 59000000.00
CBT income_statement (quarterly, 2025-09-30) — Research And Development: 15000000.00
CBT balance_sheet (annual, 2025-09-30) — Retained Earnings: 1835000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1835000000.00
CBT cash_flow (annual, 2025-09-30) — Sale Of Business: 0.00
CBT cash_flow (annual, 2025-09-30) — Sale Of PPE: 0.00
CBT income_statement (annual, 2025-09-30) — Selling General And Administration: 260000000.00
CBT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 68000000.00
CBT balance_sheet (annual, 2025-09-30) — Share Issued: 52962353.00
CBT balance_sheet (quarterly, 2025-09-30) — Share Issued: 52962353.00
CBT cash_flow (annual, 2025-09-30) — Short Term Debt Issuance: 19000000.00
CBT cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: -47000000.00
CBT cash_flow (annual, 2025-09-30) — Short Term Debt Payments: -50000000.00
CBT cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -39000000.00
CBT income_statement (annual, 2025-09-30) — Special Income Charges: 0.00
CBT cash_flow (annual, 2025-09-30) — Stock Based Compensation: 24000000.00
CBT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5000000.00
CBT balance_sheet (annual, 2025-09-30) — Stockholders Equity: 1550000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1550000000.00
CBT balance_sheet (annual, 2025-09-30) — Tangible Book Value: 1361000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1361000000.00
CBT income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (annual, 2025-09-30) — Tax Provision: 196000000.00
CBT income_statement (quarterly, 2025-09-30) — Tax Provision: 63000000.00
CBT income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.35